Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 504,158 | 2,063,805 | 1,512,991 | 1,008,515 | 501,075 |
| Accounts payable and accrued liabilities | -460,093 | -1,664,491 | -1,227,911 | -835,174 | -428,733 |
| Other Working Capital | 18,195 | 259,248 | 181,169 | 101,621 | 35,601 |
| Other Operating Activity | -38,243 | -392,082 | -286,005 | -166,060 | -72,683 |
| Operating Cash Flow | $24,017 | $266,480 | $180,244 | $108,902 | $35,260 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,686 | -222,619 | -187,008 | -144,637 | -34,647 |
| PPE Investments | -34,077 | -136,544 | -112,135 | -75,583 | -34,654 |
| Net Acquisitions | -64,056 | -39,443 | -38,479 | -18,589 | -15,329 |
| Purchase Sale Intangibles | -463 | -1,780 | -1,724 | -1,233 | -245 |
| Other Investing Activity | -463 | -1,780 | -3,142 | 1,971 | -1,655 |
| Investing Cash Flow | $-108,282 | $-400,386 | $-340,764 | $-236,838 | $-86,285 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -74 | -620 | -496 | -367 | -225 |
| Common Stock Issued | 3,135 | 10,611 | 8,958 | 6,212 | 3,464 |
| Common Stock Repurchased | N/A | -101 | -101 | -101 | N/A |
| Other Financing Activity | -10,487 | 2,698 | 712 | 775 | 480 |
| Financing Cash Flow | $-7,426 | $12,588 | $9,073 | $6,519 | $3,719 |
| Exchange Rate Effect | -3,068 | 10,475 | 3,673 | 3,673 | 6,887 |
| Beginning Cash Position | 463,388 | 574,231 | 574,231 | 574,231 | 574,231 |
| End Cash Position | 368,629 | 463,388 | 426,457 | 456,487 | 533,812 |
| Net Cash Flow | $-94,759 | $-110,843 | $-147,774 | $-117,744 | $-40,419 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,017 | 266,480 | 180,244 | 108,902 | 35,260 |
| Capital Expenditure | -34,103 | -142,869 | -112,366 | -75,697 | -34,654 |
| Free Cash Flow | -10,086 | 123,611 | 67,878 | 33,205 | 606 |